Dr. Ghohestani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24165 W IH 10
Suite 102
San Antonio, TX 78257Phone+1 210-698-6777
Summary
- Dr. Reza Ghohestani is a dermatologist in San Antonio, TX and is affiliated with University Health System. He specializes in dermatologic surgery and is experienced in general dermatology, hair disorders, keloid, dermatitis, and dermatologic surgery.
Education & Training
- Shiraz University of Medical SciencesClass of 1993
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology
- University of Pennsylvania Health SystemResidency, Surgery
- Claude Bernard UniversityPh.D., Cutaneous Biol & Immunol, Summa Cum Laude
- Claude Bernard University, Lyon & Univ.M.Sc., Cosmetology
- Claude Bernard University, LyonMS, Immunology
Certifications & Licensure
- TX State Medical License Active through 2025
- PA State Medical License Active through 2022
Awards, Honors, & Recognition
- The 2010-2018 Top San Antonio Doctor's Award San Antonio, 2010-2019
- The 2010-2018 Patient's Choice Physician Award Patients Choice Award, 2010-2018
- Physician/Scientist Career Development Award Dermatology Foundation, 2007
- Join now to see all
Clinical Trials
- Retrospective Study of Keloid Disorder Start of enrollment: 2016 Sep 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 502 citationsThe first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.Lawrence S. Chan, A. Razzaque Ahmed, Grant J. Anhalt, Wolfgang Bernauer, Kevin D. Cooper
Archives of Dermatology. 2002-03-01 - 44 citationsIgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)Reza F. Ghohestani, E. Cozzani, Emmanuel Delaporte, J.-F. Nicolas, Aurora Parodi
Journal of Clinical Immunology. 1998-05-01 - 49 citationsComparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2Reza F. Ghohestani, Jean Kanitakis, J.-F. Nicolas, Emanuele Cozzani, A. Claudy
The British Journal of Dermatology. 1996-07-01
Journal Articles
- Compositional differences between infant and adult human corneal basement membranesKabosova A, Azar DT, Bannikov GA, Campbell KP, Durbeej M, Ghohestani RF, et al, Invest Ophthalmol Vis Sci., 1/1/2007
- Circulating IgA Autoantibodies to Epidermal Transglutaminase 3 Can Not Distinguish Dermatitis Herpetiformis from Celiac DiseaseGhahestani AS, Nikbakht N, Fry L, Reunala T, Uitto J, Ghohestani RF, J Invest Dermatol, 1/1/2004
- The a5 and a6 chains of type IV collagen are the target of IgG and IgA autoantibodies in a novel autoimmune disease characterized by crescentic glomerulonephritis and ...Ghohestani RF, Barria M, Webster G, Claudy A., J Am Acad Derm, 1/1/2004
- Join now to see all
Books/Book Chapters
Lectures
- What's New on Keloid ResearchRome, Italy
- Overlapping clinical manifestations in cicatricial pemphigoidLisbon, PO
- New concepts in immunopathology of bullous pemphigoidNice, IT
- Join now to see all
Grant Support
- Characterization Of Novel 168 Kappa D Epithelial AntigenNational Institute Of Dental &Craniofacial Research2001–2002
Committees
- Panel Reviewer, NIH Study Section
External Links
- Texas Institute of Dermatology, Laser and Cosmetic Surgeryhttps://www.txid.org
- Texas Institute of Dermatology, Laser and Cosmetic Surgeryhttp://www.sanantoniodermatology.org
- Texas Institute of Dermatology, Laser and Cosmetic Surgeryhttps://www.dermatologistinsanantonio.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: